Press Releases

View Archive: 2011 | 2010 | 2009 | 2008 | 2007

11.9.10
Hyperion Therapeutics Elects David W. Gryska to Board of Directors

11.2.10
Hyperion Therapeutics’ Glycerol Phenylbutyrate Meets Primary Endpoint in Phase III Pivotal Study in Urea Cycle Disorders

10.18.10
Hyperion Therapeutics Receives FDA Fast Track Designation for Glycerol Phenylbutyrate for the Treatment of Urea Cycle Disorders

6.4.10
Hyperion Therapeutics to Present at Needham Healthcare Conference

Recent Press Releases